© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
[2025] FCA 572
Federal Court of Australia
2025-05-20
Jackman J
Original judgment source is linked above.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Any document/s recording or evidencing the Prospective Applicant's belief that it may have the right to obtain relief in the Court from the Prospective Respondent for infringement of the Oxford Nanopore Patents, as described in paragraphs 33 to 34 of the affidavit of James (Spike) Willcocks affirmed 13 March 2025 (Affidavit), including board minutes and resolution/s.
[Definition in original].
During the course of oral argument, counsel for MGI corrected the reference to para [33] in that category so that it refers to para [32] of the Affidavit.
Inconsistency is accordingly at the heart of the inquiry. Whilst unfairness may inform the consideration of whether or not there is inconsistency, the test is not one of unfairness "operating at large".
Any document/s recording or evidencing any delegation of authority relevant to the making of any decision by the Prospective Applicant to start a proceeding in the Court against the Prospective Respondent to obtain relief for patent infringement, including but not limited to any delegation of authority from the Prospective Applicant to:
(a) Dr Willcocks; and/or
(b) Jordan Herman (Senior Vice President and General Counsel); and/or
(c) Stephen Hash (Global Litigation Counsel); and/or
(d) Dr Gordon Sanghera (Chief Executive Officer).
See paragraphs 8, 9 and 38 of the Affidavit.
I certify that the preceding sixteen (16) numbered paragraphs are a true copy of the Reasons for Judgment of the Honourable Justice Jackman.
Oxford Nanopore Technologies Plc
MGI Australia Pty Ltd [2025] FCA 572
(2019) 369 ALR 267
(2006) 151 FCR 341
(2005) 142 FCR 428